ZA86967B - Alkanolamine derivatives - Google Patents
Alkanolamine derivativesInfo
- Publication number
- ZA86967B ZA86967B ZA86967A ZA86967A ZA86967B ZA 86967 B ZA86967 B ZA 86967B ZA 86967 A ZA86967 A ZA 86967A ZA 86967 A ZA86967 A ZA 86967A ZA 86967 B ZA86967 B ZA 86967B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkanolamine derivatives
- alkanolamine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858503425A GB8503425D0 (en) | 1985-02-11 | 1985-02-11 | Alkanolamine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA86967B true ZA86967B (en) | 1986-11-26 |
Family
ID=10574270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA86967A ZA86967B (en) | 1985-02-11 | 1986-02-10 | Alkanolamine derivatives |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4873254A (fi) |
| EP (1) | EP0194751B1 (fi) |
| JP (1) | JPH0819100B2 (fi) |
| KR (1) | KR860006443A (fi) |
| AU (1) | AU5339486A (fi) |
| CS (1) | CS273172B2 (fi) |
| DD (1) | DD250533A5 (fi) |
| DE (1) | DE3684803D1 (fi) |
| DK (1) | DK66186A (fi) |
| ES (2) | ES8802139A1 (fi) |
| FI (1) | FI860621A (fi) |
| GB (2) | GB8503425D0 (fi) |
| GR (1) | GR860369B (fi) |
| HU (1) | HU196179B (fi) |
| NO (1) | NO860465L (fi) |
| NZ (1) | NZ215083A (fi) |
| PH (1) | PH22683A (fi) |
| PL (2) | PL149828B1 (fi) |
| PT (1) | PT82008B (fi) |
| SU (1) | SU1590041A3 (fi) |
| ZA (1) | ZA86967B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6112662A (ja) * | 1984-06-28 | 1986-01-21 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体及びその製法 |
| EP0276552A1 (en) * | 1986-12-08 | 1988-08-03 | Yamanouchi Pharmaceutical Co. Ltd. | 1,4-dihydropyridine derivatives and their production |
| GB9102031D0 (en) * | 1991-01-30 | 1991-03-13 | Fujisawa Pharmaceutical Co | Dihydropyridine compounds,and process for their preparation |
| WO2000005209A1 (en) * | 1998-07-23 | 2000-02-03 | Lin, Tong-Ho | GUAIACOXYPROPANOLAMINES WITH α/β-ADRENERGIC BLOCKING ACTIVITY |
| JP5592265B2 (ja) * | 2007-11-01 | 2014-09-17 | アキュセラ インコーポレイテッド | 眼の疾患及び障害治療用のアミン誘導体化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB1409865A (en) * | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
| US4500527A (en) * | 1983-06-22 | 1985-02-19 | Usv Pharmaceutical Corporation | Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines |
| JPS6112662A (ja) * | 1984-06-28 | 1986-01-21 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体及びその製法 |
-
1985
- 1985-02-11 GB GB858503425A patent/GB8503425D0/en active Pending
-
1986
- 1986-02-04 GB GB868602704A patent/GB8602704D0/en active Pending
- 1986-02-07 GR GR860369A patent/GR860369B/el unknown
- 1986-02-10 EP EP86300884A patent/EP0194751B1/en not_active Expired - Lifetime
- 1986-02-10 DE DE8686300884T patent/DE3684803D1/de not_active Expired - Lifetime
- 1986-02-10 PT PT82008A patent/PT82008B/pt not_active IP Right Cessation
- 1986-02-10 NZ NZ215083A patent/NZ215083A/xx unknown
- 1986-02-10 DD DD86286947A patent/DD250533A5/de unknown
- 1986-02-10 SU SU864027023A patent/SU1590041A3/ru active
- 1986-02-10 ZA ZA86967A patent/ZA86967B/xx unknown
- 1986-02-10 NO NO860465A patent/NO860465L/no unknown
- 1986-02-10 HU HU86535A patent/HU196179B/hu not_active IP Right Cessation
- 1986-02-10 CS CS91186A patent/CS273172B2/cs unknown
- 1986-02-11 FI FI860621A patent/FI860621A/fi not_active Application Discontinuation
- 1986-02-11 PH PH33404A patent/PH22683A/en unknown
- 1986-02-11 AU AU53394/86A patent/AU5339486A/en not_active Abandoned
- 1986-02-11 US US07/828,363 patent/US4873254A/en not_active Expired - Lifetime
- 1986-02-11 ES ES551844A patent/ES8802139A1/es not_active Expired
- 1986-02-11 PL PL1986257902A patent/PL149828B1/pl unknown
- 1986-02-11 KR KR1019860000921A patent/KR860006443A/ko not_active Application Discontinuation
- 1986-02-11 PL PL1986265252A patent/PL153857B1/pl unknown
- 1986-02-11 DK DK66186A patent/DK66186A/da not_active Application Discontinuation
- 1986-02-12 JP JP61028760A patent/JPH0819100B2/ja not_active Expired - Lifetime
-
1987
- 1987-07-16 ES ES557630A patent/ES8802496A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PL153857B1 (en) | 1991-06-28 |
| CS91186A2 (en) | 1990-07-12 |
| PL257902A1 (en) | 1988-03-03 |
| FI860621A0 (fi) | 1986-02-11 |
| CS273172B2 (en) | 1991-03-12 |
| DK66186D0 (da) | 1986-02-11 |
| DD250533A5 (de) | 1987-10-14 |
| GB8503425D0 (en) | 1985-03-13 |
| HUT40415A (en) | 1986-12-28 |
| HU196179B (en) | 1988-10-28 |
| US4873254A (en) | 1989-10-10 |
| AU5339486A (en) | 1986-08-14 |
| EP0194751A1 (en) | 1986-09-17 |
| JPS61233669A (ja) | 1986-10-17 |
| FI860621A (fi) | 1986-08-12 |
| JPH0819100B2 (ja) | 1996-02-28 |
| DE3684803D1 (de) | 1992-05-21 |
| GB8602704D0 (en) | 1986-03-12 |
| ES8802139A1 (es) | 1988-04-01 |
| NO860465L (no) | 1986-08-12 |
| PL149828B1 (en) | 1990-03-31 |
| DK66186A (da) | 1986-08-12 |
| PT82008A (en) | 1986-03-01 |
| ES8802496A1 (es) | 1988-07-01 |
| PT82008B (pt) | 1988-07-01 |
| EP0194751B1 (en) | 1992-04-15 |
| KR860006443A (ko) | 1986-09-11 |
| SU1590041A3 (ru) | 1990-08-30 |
| PL265252A1 (en) | 1988-06-09 |
| ES551844A0 (es) | 1988-04-01 |
| ES557630A0 (es) | 1988-07-01 |
| PH22683A (en) | 1988-11-14 |
| NZ215083A (en) | 1989-10-27 |
| GR860369B (en) | 1986-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0191562A3 (en) | Tetrahydrocarbazolone derivatives | |
| GB8620638D0 (en) | Derivatives | |
| GB8617292D0 (en) | Poly-4-aminopyyrrole-2-carboxamido derivatives | |
| GB8601292D0 (en) | 13beta-alkylmilbemycin derivatives | |
| GB8627491D0 (en) | 5-phenyl-2-oxazole derivatives | |
| GB2176181B (en) | Aryltetralin derivatives | |
| GB8614176D0 (en) | Piperonylcarboxamido derivatives | |
| GB2172286B (en) | Tetraprenylamine derivatives | |
| GB2174703B (en) | Pyridinylpiperazine derivatives | |
| GB2177692B (en) | Diazinylpiperidine derivatives | |
| GB8623513D0 (en) | Glucosylmoranoline derivatives | |
| GB8602704D0 (en) | Alkanolamine derivatives | |
| GB8520631D0 (en) | Derivatives | |
| GB8623075D0 (en) | Bicyclocatechol derivatives | |
| GB8511892D0 (en) | Fluoralkane derivatives | |
| GB2177695B (en) | Aminoalkylamide derivatives | |
| GB8600575D0 (en) | Benzonorbornene derivatives | |
| GB2174092B (en) | Eburnamenine derivatives | |
| GB2177090B (en) | 10-alpha-methoxy-6-methyl-ergoline derivatives | |
| GB8630780D0 (en) | Estradiene derivatives | |
| GB8518919D0 (en) | Alkanolamine derivatives | |
| GB8630781D0 (en) | Estrene derivatives | |
| GB8508422D0 (en) | Punaglandin derivatives | |
| IE842684L (en) | Alkanolamine derivatives | |
| GB8501656D0 (en) | D-nor-7-ergoline derivatives |